AstraZeneca’s patent on asthma drug invalidated by US court – Yahoo News


euronews

AstraZeneca's patent on asthma drug invalidated by US court
Yahoo News
NEW YORK (Reuters) – A U.S. federal judge ruled late on Friday that AstraZeneca PLC's patent on its Pulmicort Repsules treatment for asthma was invalid, opening up the market to a second, cheaper generic version. Actavis Plc said that the U.S. District …
Actavis launches Pulmicort Respules generic on AZ legal lossPharmaTimes

all 2 news articles »

View full post on asthma – Google News

Allergy-Induced Asthma Thwarted by Anti-Inflammatory Drug – Lung Disease News


Lung Disease News

Allergy-Induced Asthma Thwarted by Anti-Inflammatory Drug
Lung Disease News
asthma Allergy-induced asthma may be prevented by a drug that acts on serotonin receptors, according to work from Louisiana State University Health New Orleans. Researchers at LSU showed that (R)-DOI, a “psychedelic” drug that activates serotonin …
Psychedelic drug prevents asthma in miceHealthCentral.com

all 2 news articles »

View full post on asthma – Google News

Asthma development prevented with psychedelic drug in mouse study – Medical News Today


Medical News Today

Asthma development prevented with psychedelic drug in mouse study
Medical News Today
Asthma causes the airways to narrow and become inflamed. When these airways react to certain inhaled substances, the muscles around them tighten, and increased levels of mucus can be produced. Together, these reactions lead to symptoms such as …
Mind-altering Drug Stymies Asthma DevelopmentGenetic Engineering & Biotechnology News
Study finds psychedelic drug prevents asthma development in miceMedical Xpress
Far out: Psychedelic drug prevents asthma development in miceScience Codex
Science World Report
all 12 news articles »

View full post on asthma – Google News

Mind-altering Drug Stymies Asthma Development – Genetic Engineering & Biotechnology News


Science World Report

Mind-altering Drug Stymies Asthma Development
Genetic Engineering & Biotechnology News
Scientists at the Louisiana State University Health New Orleans School of Medicine have found that a psychedelic drug, (R)-DOI, prevents the development of allergic asthma in a mouse model. The effects are potent and effective at a concentration 50-100 …
Study finds psychedelic drug prevents asthma development in miceMedical Xpress
Far out: Psychedelic drug prevents asthma development in miceScience Codex
Could A Psychedelic Drug Prevent Asthma?Science World Report
Medical News Today
all 12 news articles »

View full post on asthma – Google News

Theravance/Glaxos Asthma Drug Under FDA Panel Review – Zacks.com

Theravance/Glaxos Asthma Drug Under FDA Panel Review
Zacks.com
We note that Theravance and partner GlaxoSmithKline (GSK – Analyst Report) are seeking to expand the label of Breo Ellipta in the U.S. for the once-daily treatment of asthma in patients aged 12 years and above. A final response from the FDA is expected
FDA advisory committee to review Theravance's BREO ELLIPTA (FF/VI) for asthmaPharmaceutical Business Review

all 17 news articles »

View full post on asthma – Google News